Daniel Burnett

Daniel Burnett is a highly accomplished professional with a diverse educational background and extensive experience in the field of medicine, business, and bioengineering.

He holds an MBA from Duke University - The Fuqua School of Business, an MD MBA in Engineering, Medicine, and Business from Duke University, and a Doctor of Medicine (MD) from Duke University School of Medicine. Additionally, he studied bioengineering at the University of Pennsylvania.

Throughout his career, Daniel has been associated with several notable organizations where he served in various capacities. He was the Founder at Bone Health Technologies, RESPIRIX, Perikinetics Inc, Ethonova, Inc., Potrero Medical, Channel Medsystems, Inc., EMKinetics, Theranova, LLC, Velomedix, BAROnova, and Sequana Medical AG. Moreover, he held the positions of Founder and Chairman at RESPIRIX, Founder and Director at Perikinetics Inc, Founder and Director at Ethonova, Inc., Founder and CEO at Theranova, LLC, Founder and Chief Executive Officer at Velomedix, Founder and Chief Technology Officer at BAROnova, and Founder and Chief Medical Officer at Sequana Medical AG. Furthermore, he was a General Partner at MedVenture Associates.

In addition to his entrepreneurial ventures, Daniel Burnett also has academic experience, having served as an Adjunct Assistant Professor in the Department of Bioengineering at the University of California, San Francisco. Prior to this, he worked as an Engineer at the FDA, showcasing his versatility and expertise in different professional settings.

Daniel Burnett's wealth of experience and contributions to various fields make him a valuable asset in the realms of bioengineering, business, and medicine.